EXEL Julie Smith sells $2.8M worth of shares
Feb 20, 2026, 5:33 AM
0.00%
What does EXEL do
Exelixis, an oncology company based in Alameda, California, focuses on developing treatments for difficult-to-treat cancers, with four marketed products including cabozantinib for various cancers. Founded in 2000, it employs 1,310 people.
Julie Smith sold 64,117 shares of EXEL on 18 February at $44.30 per share, worth a total of $2.8M. They now own 20,590 EXEL shares, or a 76% holding decrease.
📡️ Health Care
Insider Trades
More Signals
Feature in Progress
This section is under development. Check back soon for updates!
Cashu is the #1 way to stay ahead of the markets, know why your favourite stocks are moving and access valuation signals that smash the market.